There was also no significant difference between the percentages of CD8+CD314+ T-cells in SLE-patients with and without lupus nephritis and healthy controls, respectively (98.8 ± 1.1% vs. 98.4 ± 1.5% vs. 98.7 ± 1.3%, n.s.). This evidence concerns the gene KLRK1 and lupus nephritis.